{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:59:59Z","timestamp":1792699199080,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007281","name":"National Drug and Alcohol Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.forsciint.2021.111140","type":"journal-article","created":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T16:23:22Z","timestamp":1638721402000},"page":"111140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Characteristics of fatal \u2018novel\u2019 benzodiazepine toxicity in Australia"],"prefix":"10.1016","volume":"331","author":[{"given":"Shane","family":"Darke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Duflou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Lappin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2021.111140_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/15563650.2018.1506130","article-title":"Occurrence and time course of NPS benzodiazepines in Sweden\u2013results from intoxication cases in the STRIDA project","volume":"57","author":"B\u00e4ckberg","year":"2019","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.forsciint.2021.111140_bib2","series-title":"Disposition of Toxic Drugs and Chemicals in Man","author":"Baselt","year":"2020"},{"key":"10.1016\/j.forsciint.2021.111140_bib3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3390\/ph14060560","article-title":"Designer Benzodiazepines: a review of toxicology and public health risks","volume":"4","author":"Brunetti","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.forsciint.2021.111140_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/hup.2222","article-title":"Phenazepam abuse in the UK: an emerging problem causing serious adverse health problems, including death","volume":"27","author":"Corkery","year":"2012","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.forsciint.2021.111140_bib5","unstructured":"European Monitoring Centre for Drugs and Drug Addiction New benzodiazepines in Europe \u2013 a review. Publications Office of the European Union, Luxembourg, 2021."},{"key":"10.1016\/j.forsciint.2021.111140_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11419-015-0277-6","article-title":"Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites","volume":"33","author":"Huppertz","year":"2015","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.forsciint.2021.111140_bib7","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2174\/1570159X18666200110121333","article-title":"New\/designer benzodiazepines: an analysis of the literature and psychonauts trip reports","volume":"18","author":"Orsolini L","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.forsciint.2021.111140_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/wps.20236","article-title":"Designer benzodiazepines: a new challenge","volume":"14","author":"Moosmann","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1016\/j.forsciint.2021.111140_bib9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/dar.13052","article-title":"Etizolam: a rapid review on pharmacology, non\u2010medical use and harms","volume":"39","author":"Nielsen","year":"2020","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.forsciint.2021.111140_bib10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/0025802420950273","article-title":"Flubromazolam detection in five post-mortem cases","volume":"60","author":"Abdul","year":"2020","journal-title":"Med. Sci. Law"},{"key":"10.1016\/j.forsciint.2021.111140_bib11","series-title":"Goodman & Gilman\u2019s The Pharmaceutical Basis Of Therapeutics","author":"Brunton","year":"2017"},{"key":"10.1016\/j.forsciint.2021.111140_bib12","series-title":"Handbook of Novel Psychoactive Substances","article-title":"Designer benzodiazepines: new challenges and treatment options","author":"Maskell","year":"2018"},{"key":"10.1016\/j.forsciint.2021.111140_bib13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/jat\/bkz063","article-title":"Validation of an LC-MS\/MS method for the quantification of 13 designer benzodiazepines in blood","volume":"43","author":"Mei","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2021.111140_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/10408444.2021.1907303","article-title":"Designer benzodiazepines versus prescription benzodiazepines can structural relation predict the next step?","volume":"51","author":"Moustafa","year":"2021","journal-title":"Crit. Rev.Toxicol."},{"key":"10.1016\/j.forsciint.2021.111140_bib15","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/jamainternmed.2016.4306","article-title":"Adverse effects from counterfeit alprazolam tablets","volume":"176","author":"Arens","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.forsciint.2021.111140_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.9740\/mhc.2019.05.133","article-title":"Flubromazolam overdose. A review of a new designer benzodiazepine and the role of flumazenil","volume":"9","author":"Bohnenberger","year":"2019","journal-title":"Ment. Health Clin."},{"key":"10.1016\/j.forsciint.2021.111140_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/15563650.2015.1112907","article-title":"Flubromazolam\u2013a new life-threatening designer benzodiazepine","volume":"54","author":"\u0141ukasik-G\u0142\u0119bocka","year":"2016","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.forsciint.2021.111140_bib18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.annemergmed.2014.12.019","article-title":"Overdose of etizolam: the abuse and rise of a benzodiazepine analog","volume":"65","author":"O\u2019Connell","year":"2015","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.forsciint.2021.111140_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2020.110237","article-title":"Clonazolam a new designer benzodiazepine intoxication confirmed by blood concentration","volume":"310","author":"Sommerfeld-Klatta","year":"2020","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2021.111140_bib20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/jat\/bkaa043","article-title":"Blood concentrations of designer benzodiazepines relation to impairment and findings in forensic cases","volume":"44","author":"Heide","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2021.111140_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.forsciint.2016.09.006","article-title":"Blood concentrations of new designer benzodiazepines in forensic cases","volume":"268","author":"H\u00f8iseth","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2021.111140_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.forsciint.2012.02.006","article-title":"Phenazepam abuse in Finland: findings from apprehended drivers, post-mortem cases and police confiscations","volume":"220","author":"Kriikku P","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2021.111140_bib23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jat\/34.8.527","article-title":"Fatality involving the ingestion of phenazepam and poppy seed tea","volume":"34","author":"Bailey","year":"2010","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2021.111140_bib24","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00414-017-1541-6","article-title":"Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer","volume":"131","author":"El Balkhi","year":"2017","journal-title":"Int. J. Leg. Med."},{"key":"10.1016\/j.forsciint.2021.111140_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jat\/bkaa146","article-title":"A case series of etizolam in opioid-related deaths","volume":"45","author":"Gevorkyan","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2021.111140_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/0025802420973814","article-title":"Femoral blood concentrations of the designer benzodiazepine etizolam in post-mortem cases","volume":"61","author":"Hikin","year":"2021","journal-title":"Med. Sci. Law"},{"key":"10.1016\/j.forsciint.2021.111140_bib27","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.forsciint.2014.08.013","article-title":"Lethal poisonings with AH-7921 in combination with other substances","volume":"244","author":"Karinen","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2021.111140_bib28","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/dta.2391","article-title":"Mixed intoxication by the synthetic opioid U\u201047700 and the benzodiazepine flubromazepam with lethal outcome: pharmacokinetic data","volume":"10","author":"Koch","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2021.111140_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2019.109959","article-title":"Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine","volume":"303","author":"Lehmann","year":"2019","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2021.111140_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.forsciint.2016.02.017","article-title":"A fatal intoxication related to MDPV and pentedrone combined with antipsychotic and antidepressant substances in Cyprus","volume":"265","author":"Liveri","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2021.111140_bib31","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.forsciint.2008.08.012","article-title":"Case report: etizolam and its major metabolites in two unnatural death cases","volume":"182","author":"Nakamae","year":"2008","journal-title":"Forensic Sci. Int"},{"key":"10.1016\/j.forsciint.2021.111140_bib32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11419-020-00568-1","article-title":"Fatal intoxication with U-47700 in combination with other NPS (N-ethylhexedrone, adinazolam, 4-CIC, 4-CMC) confirmed by identification and quantification in autopsy specimens and evidences","volume":"39","author":"Nowak","year":"2021","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.forsciint.2021.111140_bib33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jat\/bkw012","article-title":"Analysis of MT-45, a novel synthetic opioid, in human whole blood by LC\u2013MS-MS and its identification in a drug-related death","volume":"40","author":"Papsun","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2021.111140_bib34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jat\/bky039","article-title":"A case study involving U-47700, diclazepam and flubromazepam\u2014application of retrospective analysis of HRMS data","volume":"42","author":"Partridge","year":"2018","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2021.111140_bib35","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/jat\/bkaa098","article-title":"Quantification of flualprazolam in blood by LC\u2013MS-MS a case series of nine deaths","volume":"45","author":"Rice","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2021.111140_bib36","first-page":"38","article-title":"An autopsy case of multiple psychotropic drug poisoning","volume":"56","author":"Tanaka","year":"2011","journal-title":"Soud. Lek."},{"key":"10.1016\/j.forsciint.2021.111140_bib37","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1039\/D0AY00560F","article-title":"Determination of prescribed and designer benzodiazepines and metabolites in influent wastewater","author":"Bade","year":"2020","journal-title":"Anal. Method"},{"key":"10.1016\/j.forsciint.2021.111140_bib38","article-title":"What\u2019s in fake \u2018Xanax\u2019? a dosage survey of designer benzodiazepines in counterfeit pharmaceutical tablets","author":"Blakey","year":"2021","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2021.111140_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0025-6196(12)64946-5","article-title":"Age-related changes in normal human hearts during the first 10 decades of life. part II (Maturity): a quantitative anatomic study of 765 specimens from subjects 20 to 99 years old","volume":"63","author":"Kitzman","year":"1998","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.forsciint.2021.111140_bib40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0025-6196(12)64945-3","article-title":"Age-related changes in normal human hearts during the first 10 decades of life. part I (growth) a quantitative anatomic study of 200 specimens from subjects from birth to 19 years old","volume":"63","author":"Scholz","year":"1998","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.forsciint.2021.111140_bib41","unstructured":"IBM inc. SPSS for Windows 26.0. SPSS inc, Chicago, IL, 2019."},{"key":"10.1016\/j.forsciint.2021.111140_bib42","series-title":"Karch\u2019s Pathology of Drug Abuse","author":"Karch","year":"2015"},{"key":"10.1016\/j.forsciint.2021.111140_bib43","series-title":"The Clinician\u2018s Guide to Illicit Drugs and Health","author":"Darke","year":"2019"}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073821004606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073821004606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:07:32Z","timestamp":1759946852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073821004606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":43,"alternative-id":["S0379073821004606"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2021.111140","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of fatal \u2018novel\u2019 benzodiazepine toxicity in Australia","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2021.111140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111140"}}